tiprankstipranks
Trending News
More News >
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Germany Market

Dermapharm Holding SE (DMP) Ratios

Compare
13 Followers

Dermapharm Holding SE Ratios

DE:DMP's free cash flow for Q3 2025 was €0.36. For the 2025 fiscal year, DE:DMP's free cash flow was decreased by € and operating cash flow was €0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.20 1.82 1.60 2.45 3.34
Quick Ratio
1.04 0.78 0.79 1.30 1.79
Cash Ratio
0.50 0.37 0.40 0.69 1.03
Solvency Ratio
0.14 0.14 0.10 0.27 0.29
Operating Cash Flow Ratio
0.64 0.62 0.56 1.32 1.61
Short-Term Operating Cash Flow Coverage
2.40 2.37 1.97 154.38 105.24
Net Current Asset Value
€ -827.29M€ -878.23M€ -985.13M€ -346.40M€ -387.91M
Leverage Ratios
Debt-to-Assets Ratio
0.48 0.47 0.50 0.37 0.41
Debt-to-Equity Ratio
1.56 1.62 2.00 0.97 1.17
Debt-to-Capital Ratio
0.61 0.62 0.67 0.49 0.54
Long-Term Debt-to-Capital Ratio
0.59 0.59 0.64 0.49 0.53
Financial Leverage Ratio
3.26 3.44 4.01 2.66 2.83
Debt Service Coverage Ratio
1.89 1.82 1.32 17.32 24.43
Interest Coverage Ratio
3.79 3.71 3.33 19.75 33.77
Debt to Market Cap
0.54 0.46 0.47 0.25 0.12
Interest Debt Per Share
19.84 19.28 21.09 9.82 10.94
Net Debt to EBITDA
2.77 2.67 3.47 1.11 1.17
Profitability Margins
Gross Profit Margin
58.96%64.96%63.34%64.49%65.83%
EBIT Margin
19.32%19.51%14.18%22.31%32.01%
EBITDA Margin
26.87%27.18%23.39%32.18%37.98%
Operating Profit Margin
18.70%18.37%16.11%23.78%31.65%
Pretax Profit Margin
14.82%14.57%9.34%21.11%31.07%
Net Profit Margin
10.00%9.64%5.49%13.10%22.23%
Continuous Operations Profit Margin
9.85%9.46%5.33%14.26%22.12%
Net Income Per EBT
67.50%66.15%58.84%62.06%71.54%
EBT Per EBIT
79.23%79.29%57.95%88.76%98.16%
Return on Assets (ROA)
5.48%5.47%2.89%9.50%14.90%
Return on Equity (ROE)
18.56%18.83%11.57%25.25%42.14%
Return on Capital Employed (ROCE)
11.89%12.37%10.36%20.39%23.85%
Return on Invested Capital (ROIC)
7.58%7.65%5.55%12.45%16.93%
Return on Tangible Assets
11.03%11.48%6.01%16.05%24.73%
Earnings Yield
6.18%5.43%2.74%6.65%4.36%
Efficiency Ratios
Receivables Turnover
8.85 11.24 11.90 10.60 13.00
Payables Turnover
5.07 4.36 4.80 6.49 6.18
Inventory Turnover
1.40 1.22 1.30 1.45 1.34
Fixed Asset Turnover
3.71 3.75 3.43 4.54 4.24
Asset Turnover
0.55 0.57 0.53 0.73 0.67
Working Capital Turnover Ratio
3.55 4.70 4.11 3.02 2.99
Cash Conversion Cycle
229.70 248.68 235.99 230.74 241.52
Days of Sales Outstanding
41.24 32.46 30.67 34.45 28.07
Days of Inventory Outstanding
260.39 299.85 281.31 252.55 272.47
Days of Payables Outstanding
71.94 83.63 75.98 56.26 59.02
Operating Cycle
301.63 332.31 311.98 287.00 300.54
Cash Flow Ratios
Operating Cash Flow Per Share
3.46 3.74 4.08 5.36 4.65
Free Cash Flow Per Share
2.68 3.03 3.30 4.63 3.51
CapEx Per Share
0.78 0.71 0.77 0.72 1.14
Free Cash Flow to Operating Cash Flow
0.77 0.81 0.81 0.86 0.76
Dividend Paid and CapEx Coverage Ratio
2.06 2.35 2.24 1.85 2.31
Capital Expenditure Coverage Ratio
4.42 5.27 5.28 7.40 4.09
Operating Cash Flow Coverage Ratio
0.18 0.21 0.20 0.56 0.43
Operating Cash Flow to Sales Ratio
0.16 0.17 0.19 0.28 0.27
Free Cash Flow Yield
7.68%7.79%7.80%12.35%3.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.17 18.41 36.55 15.05 22.94
Price-to-Sales (P/S) Ratio
1.62 1.77 2.01 1.97 5.10
Price-to-Book (P/B) Ratio
2.89 3.47 4.23 3.80 9.67
Price-to-Free Cash Flow (P/FCF) Ratio
13.02 12.84 12.82 8.10 25.42
Price-to-Operating Cash Flow Ratio
10.07 10.40 10.39 7.00 19.20
Price-to-Earnings Growth (PEG) Ratio
1.89 0.22 -0.68 -0.42 0.16
Price-to-Fair Value
2.89 3.47 4.23 3.80 9.67
Enterprise Value Multiple
8.79 9.20 12.06 7.24 14.60
Enterprise Value
2.74B 2.95B 3.20B 2.39B 5.23B
EV to EBITDA
8.79 9.20 12.06 7.24 14.60
EV to Sales
2.36 2.50 2.82 2.33 5.54
EV to Free Cash Flow
19.01 18.10 18.00 9.56 27.64
EV to Operating Cash Flow
14.71 14.66 14.59 8.27 20.88
Tangible Book Value Per Share
-7.78 -8.92 -10.74 -0.81 -1.11
Shareholders’ Equity Per Share
12.06 11.23 10.01 9.87 9.24
Tax and Other Ratios
Effective Tax Rate
0.34 0.35 0.43 0.39 0.29
Revenue Per Share
21.55 21.93 21.09 19.03 17.51
Net Income Per Share
2.16 2.11 1.16 2.49 3.89
Tax Burden
0.67 0.66 0.59 0.62 0.72
Interest Burden
0.77 0.75 0.66 0.95 0.97
Research & Development to Revenue
0.00 <0.01 <0.01 0.01 0.02
SG&A to Revenue
0.00 0.01 0.02 0.02 0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.18 1.17 3.52 1.33 0.85
Currency in EUR